These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34667041)

  • 1. Sight-threatening progressive corneo-scleral involvement in porphyria cutanea tarda.
    Prasad S; Vidhata V; Prasad S
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34667041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleral Compromise in Hereditary Porphyria Cutanea Tarda.
    Paez Soria EA; Cremona FA; Lucero Saá F; Chiaradía P
    J Curr Ophthalmol; 2021; 33(1):91-94. PubMed ID: 34084964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyria cutanea tarda: a case report.
    Usta Atmaca H; Akbas F
    J Med Case Rep; 2019 Jan; 13(1):17. PubMed ID: 30661508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Report of Porphyria Cutanea Tarda with Hepatitis-C Virus Co-infection.
    Hasan MN; Bhuiyan MR; Ferdous SH; Hossain A; Banik MC; Rahman MA
    Mymensingh Med J; 2023 Apr; 32(2):584-586. PubMed ID: 37002774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular complications in 2 cases with porphyria.
    Altiparmak UE; Oflu Y; Kocaoglu FA; Katircioglu YA; Duman S
    Cornea; 2008 Oct; 27(9):1093-6. PubMed ID: 18812782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
    Bygum A; Christiansen L; Petersen NE; Hørder M; Thomsen K; Brandrup F
    Acta Derm Venereol; 2003; 83(2):115-20. PubMed ID: 12735639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Corneal Melt in Patient with Porphyria Cutanea Tarda in Presence of Another Risk Factor.
    Arya SK; Raj A; Kohli P; Bamotra RK
    Ocul Immunol Inflamm; 2019; 27(4):610-613. PubMed ID: 29370566
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients.
    Muñoz-Santos C; Guilabert A; Moreno N; To-Figueras J; Badenas C; Darwich E; Herrero C
    Medicine (Baltimore); 2010 Mar; 89(2):69-74. PubMed ID: 20517178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular manifestations in porphyria cutanea tarda.
    Gogri PY; Misra NS; Misra S
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24811555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
    Brady JJ; Jackson HA; Roberts AG; Morgan RR; Whatley SD; Rowlands GL; Darby C; Shudell E; Watson R; Paiker J; Worwood MW; Elder GH
    J Invest Dermatol; 2000 Nov; 115(5):868-74. PubMed ID: 11069625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda in a patient with HIV-infection.
    Almehmi A; Deliri H; Szego GG; Teague AC; Pfister AK; Martin SA
    W V Med J; 2005; 101(1):19-21. PubMed ID: 15861867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte uroporphyrinogen decarboxylase activity: diagnostic value and relationship with clinical features in hereditary porphyria cutanea tarda.
    Camagna A; Del Duca P; Petrinelli P; Borelli LG; Ciancio L; Cipollone L; Misasi G; Manfredi MR; Dionisi S; de Martinis C
    Am J Med Sci; 1998 Jan; 315(1):59-62. PubMed ID: 9427577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coexistence of hereditary coproporphyria and porphyria cutanea tarda: a new form of dual porphyria].
    Doss MO; Gross U; Puy H; Doss M; Kühnel A; Jacob K; Deybach JC; Nordmann Y
    Med Klin (Munich); 2002 Jan; 97(1):1-5. PubMed ID: 11831056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
    Elder GH; Sheppard DM; De Salamanca RE; Olmos A
    Clin Sci (Lond); 1980 Jun; 58(6):477-84. PubMed ID: 7428280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.
    Roberts AG; Elder GH; De Salamanca RE; Herrero C; Lecha M; Mascaro JM
    J Invest Dermatol; 1995 Apr; 104(4):500-2. PubMed ID: 7706766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Porphyria cutanea tarda and hepatoerythropoietic porphyria].
    Nonaka S; Takamiyagi A
    Nihon Rinsho; 1995 Jun; 53(6):1427-32. PubMed ID: 7616658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic aspects of porphyria cutanea tarda.
    Lambrecht RW; Thapar M; Bonkovsky HL
    Semin Liver Dis; 2007 Feb; 27(1):99-108. PubMed ID: 17295179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis.
    Ruggian JC; Fishbane S; Demento FJ; Maesaka JK; Frei GL
    J Am Soc Nephrol; 1996 Mar; 7(3):397-402. PubMed ID: 8704104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyria Cutanea Tarda Presenting as Erythema-multiforme Like Lesions.
    Parajuli N; Jha HK; Jonkman MF
    J Nepal Health Res Counc; 2019 Apr; 17(1):119-121. PubMed ID: 31110391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.